论文部分内容阅读
AIM:To evaluate the clinical effect of high-intensity focusedultrasound(HIFU)in the treatment of patients with livercancer.METHODS:HIFU treatment was performed in 100 patientswith liver cancer under general anesthesia and by atargeted ultrasound.Evaluation of efficacy was made onthe basis of clinical symptoms,liver function tests,AFP,MRI or CT before and after the treatment.RESULTS:After HIFU treatment,clinical symptoms wererelieved in 86.6%(71/82)of patients.The ascitesdisappeared in 6 patients.ALT(95±44)U/L and AST(114±58)U/L before HIFU treatment were reduced tonormal in 83.3%(30/36)and 72.9%(35/48)patients,respectively,after the treatment.AFP was lowered by morethan 50% in 65.3%(32/49)patients.After HIFU treatment,MRI or CT findings indicated coagulation necrosis and bloodsupply reduction or disappearance of tumor in the target region.CONCLUSION:HIFU can efficiently treat the patients withliver cancer.It will offer a significant noninvasive therapyfor local treatment of liver tumor.
AIM: To evaluate the clinical effect of high-intensity focusedultrasound (HIFU) in the treatment of patients with livercancer. METHODS: HIFU treatment was performed in 100 patients with liver cancer under general anesthesia and by atargeted ultrasound. Evaluation of efficacy was made on the basis of Clinical symptoms, liver function tests, AFP, MRI or CT before and after the treatment. RESULTS: After HIFU treatment, clinical symptoms were seen in 86.6% (71/82) of patients. Ascites dosed in 6 patients. UA and L and AST (114 ± 58) U / L before HIFU treatment were reduced to normal in 83.3% (30/36) and 72.9% (35/48) patients, respectively, after the treatment. AFP was lowered by more tonhan 50% in 65.3% (32/49) patients. After HIFU treatment, MRI or CT findings indicated coagulation necrosis and bloodsupply reduction or disappearance of tumor in the target region. CONCLUSION: HIFU can efficiently treat the patients withliver cancer. I will offer a significant noninvasive therapy for local treatment of liver tum or